- Filed
- Mar 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 14, 2025 | 1.32M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 1.06M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$36.91M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $21.47M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $5.83M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $5.9M |
| Current Assets | FY 2024 · Dec 31, 2023 | $36.77M |
| Total Assets | FY 2024 · Dec 31, 2023 | $38.23M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$36.08 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$36.08 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $12.69M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $23.77M |
| Net Income | FY 2024 · Dec 31, 2023 | −$38.35M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$39.91M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $61.75M |